The University of Southampton
University of Southampton Institutional Repository

Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental C-13-DHA-metabolism, altering their relationships with birthweight

Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental C-13-DHA-metabolism, altering their relationships with birthweight
Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental C-13-DHA-metabolism, altering their relationships with birthweight

Transplacental docosahexaenoic-acid (DHA) supply for fetal development is regulated by placental DHA-lipid metabolism. Both maternal diabetes and obesity are linked to possible decreased fetal circulating DHA and increased placental DHA-lipids. Since myo-inositol is a promising intervention for gestational diabetes (GDM), we aimed to determine whether myo-inositol could rectify perturbations in placental DHA metabolism associated with maternal increasing glycemia and obesity and examine links with birthweight. Term placental villous explants from 17 women representing a range of BMIs and mid-gestational glycemia, were incubated with 13C-labeled-DHA for 48 h, in 0.3 µmol/L (control) or 60 µmol/L myo-inositol. Individual newly synthesized 13C-DHA-labeled lipid species were quantified by liquid-chromatography-mass-spectrometry. Compared with controls, incubation with myo-inositol decreased most 13C-DHA-lipids in placental explants from women with higher BMI or higher glycemia, but increased 13C-DHA-lipids with normal BMI or lower glycemia. Myo-inositol also increased 13C-DHA-labeled lipids in cases of lower birthweight centile, but induced decreases at higher centiles. Myo-inositol therefore lowered DHA-lipids in placenta with high basal placental DHA-lipid production (higher BMI and glycemia) but increased DHA-lipids where basal processing capacity is low. Myo-inositol thus moderates placental DHA metabolism towards a physiological mean which may in turn moderate birthweight.

2045-2322
Watkins, Oliver C.
985df9b8-72d6-4f32-9ee3-54553c990fdc
Selvam, Preben
989ffd8a-e214-43b5-a3ce-a814fc491ee7
Pillai, Reshma Appukuttan
c6a8a2d9-eaa1-4963-8c2c-5aed5d7e0503
Cracknell-Hazra, Victoria K B
3a73f405-4c9f-41c9-83a7-2d49ef0f0313
Yong, Hannah E.J.
9d6a310c-8309-4d94-9dd2-7766cb0420ac
Sharma, Neha
c5c663b2-86e4-4e3c-8f56-c28351419587
Cazenave-Gassiot, Amaury
cc674089-b58a-493f-80a5-bbb4e377b41d
Bendt, Anne K.
3a269eb1-2755-4020-a6a1-12100ae89bd4
Godfrey, Keith M.
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Lewis, Rohan M
caaeb97d-ea69-4f7b-8adb-5fa25e2d3502
Wenk, Markus R.
d1ba356f-b0ed-4318-886a-c8f929679060
Chan, Shiao-Yng
3c9d8970-2cc4-430a-86a7-96f6029a5293
Watkins, Oliver C.
985df9b8-72d6-4f32-9ee3-54553c990fdc
Selvam, Preben
989ffd8a-e214-43b5-a3ce-a814fc491ee7
Pillai, Reshma Appukuttan
c6a8a2d9-eaa1-4963-8c2c-5aed5d7e0503
Cracknell-Hazra, Victoria K B
3a73f405-4c9f-41c9-83a7-2d49ef0f0313
Yong, Hannah E.J.
9d6a310c-8309-4d94-9dd2-7766cb0420ac
Sharma, Neha
c5c663b2-86e4-4e3c-8f56-c28351419587
Cazenave-Gassiot, Amaury
cc674089-b58a-493f-80a5-bbb4e377b41d
Bendt, Anne K.
3a269eb1-2755-4020-a6a1-12100ae89bd4
Godfrey, Keith M.
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Lewis, Rohan M
caaeb97d-ea69-4f7b-8adb-5fa25e2d3502
Wenk, Markus R.
d1ba356f-b0ed-4318-886a-c8f929679060
Chan, Shiao-Yng
3c9d8970-2cc4-430a-86a7-96f6029a5293

Watkins, Oliver C., Selvam, Preben, Pillai, Reshma Appukuttan, Cracknell-Hazra, Victoria K B, Yong, Hannah E.J., Sharma, Neha, Cazenave-Gassiot, Amaury, Bendt, Anne K., Godfrey, Keith M., Lewis, Rohan M, Wenk, Markus R. and Chan, Shiao-Yng (2022) Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental C-13-DHA-metabolism, altering their relationships with birthweight. Scientific Reports, 12 (1), [14895]. (doi:10.1038/s41598-022-18309-2).

Record type: Article

Abstract

Transplacental docosahexaenoic-acid (DHA) supply for fetal development is regulated by placental DHA-lipid metabolism. Both maternal diabetes and obesity are linked to possible decreased fetal circulating DHA and increased placental DHA-lipids. Since myo-inositol is a promising intervention for gestational diabetes (GDM), we aimed to determine whether myo-inositol could rectify perturbations in placental DHA metabolism associated with maternal increasing glycemia and obesity and examine links with birthweight. Term placental villous explants from 17 women representing a range of BMIs and mid-gestational glycemia, were incubated with 13C-labeled-DHA for 48 h, in 0.3 µmol/L (control) or 60 µmol/L myo-inositol. Individual newly synthesized 13C-DHA-labeled lipid species were quantified by liquid-chromatography-mass-spectrometry. Compared with controls, incubation with myo-inositol decreased most 13C-DHA-lipids in placental explants from women with higher BMI or higher glycemia, but increased 13C-DHA-lipids with normal BMI or lower glycemia. Myo-inositol also increased 13C-DHA-labeled lipids in cases of lower birthweight centile, but induced decreases at higher centiles. Myo-inositol therefore lowered DHA-lipids in placenta with high basal placental DHA-lipid production (higher BMI and glycemia) but increased DHA-lipids where basal processing capacity is low. Myo-inositol thus moderates placental DHA metabolism towards a physiological mean which may in turn moderate birthweight.

Text
s41598-022-18309-2 - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)

More information

e-pub ahead of print date: 1 September 2022
Additional Information: Funding This research is supported by Clinician Scientist Awards awarded to SYC from the Singapore National Medical Research Council (NMRC/CSA-INV/0010/2016, MOH-CSAINV19nov-0002), by the National University of Singapore, National University Health System Singapore and the Singapore Institute for Clinical Sciences A*STAR. The Singapore Lipidomics Incubator receives funding from the Life Sciences Institute, the National University of Singapore Yong Loo Lin School of Medicine, the National Research Foundation (grant number NRFI2015-05) and A*STAR (IAF-ICP I1901E0040). Funders played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

Identifiers

Local EPrints ID: 470346
URI: http://eprints.soton.ac.uk/id/eprint/470346
ISSN: 2045-2322
PURE UUID: c484a8de-d225-4537-91fe-797efcd44f31
ORCID for Keith M. Godfrey: ORCID iD orcid.org/0000-0002-4643-0618
ORCID for Rohan M Lewis: ORCID iD orcid.org/0000-0003-4044-9104

Catalogue record

Date deposited: 06 Oct 2022 17:03
Last modified: 17 Mar 2024 02:53

Export record

Altmetrics

Contributors

Author: Oliver C. Watkins
Author: Preben Selvam
Author: Reshma Appukuttan Pillai
Author: Victoria K B Cracknell-Hazra
Author: Hannah E.J. Yong
Author: Neha Sharma
Author: Amaury Cazenave-Gassiot
Author: Anne K. Bendt
Author: Rohan M Lewis ORCID iD
Author: Markus R. Wenk
Author: Shiao-Yng Chan

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×